Guangzhou Kingmed Diagnostics Group Co., Ltd.

SHSE:603882 Rapport sur les actions

Capitalisation boursière : CN¥14.4b

Guangzhou Kingmed Diagnostics Group Gestion

Gestion contrôle des critères 1/4

Nous ne disposons actuellement pas d’informations suffisantes sur le PDG.

Informations clés

Yaoming Liang

Directeur général

CN¥4.5m

Rémunération totale

Pourcentage du salaire du PDGn/a
Durée du mandat du directeur généralno data
Propriété du PDG16.0%
Durée moyenne d'occupation des postes de directionpas de données
Durée moyenne du mandat des membres du conseil d'administrationless than a year

Mises à jour récentes de la gestion

Recent updates

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Sep 27
Earnings Tell The Story For Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Sep 03
Guangzhou Kingmed Diagnostics Group Co., Ltd. Just Missed Revenue By 9.5%: Here's What Analysts Think Will Happen Next

Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

Aug 25
Is Guangzhou Kingmed Diagnostics Group (SHSE:603882) Using Too Much Debt?

A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Jun 04
A Look At The Fair Value Of Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)

Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

May 02
Guangzhou Kingmed Diagnostics Group's (SHSE:603882) Shareholders Have More To Worry About Than Only Soft Earnings

Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Apr 17
Investors Don't See Light At End Of Guangzhou Kingmed Diagnostics Group Co., Ltd.'s (SHSE:603882) Tunnel And Push Stock Down 26%

Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

Feb 28
Investor Optimism Abounds Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) But Growth Is Lacking

PDG

Yaoming Liang (60 yo)

no data

Titularisation

CN¥4,503,500

Compensation

Mr. Yaoming Liang serves as the Chairman of the Board and General Manager of Guangzhou Kingmed Diagnostics Group Co., Ltd. (formerly known as Guangzhou KingMed Center for Clinical Laboratory Co., Ltd) and...


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Yaoming Liang
Chairman & GMno dataCN¥4.50m15.96%
CN¥ 2.3b
Bixi Hao
Deputy GMno dataCN¥2.62m0.011%
CN¥ 1.6m
Linglai Wang
Deputy GM4.8yrsCN¥1.67m0.13%
CN¥ 19.2m
Ting Yan
Deputy GM & Directorno dataCN¥2.29m0.75%
CN¥ 108.8m
Huobao Xie
Independent Directorless than a yearpas de donnéespas de données
Zhanwen Zeng
Directorno dataCN¥1.04m0.75%
CN¥ 108.8m
Qiang Xie
Directorno datapas de donnéespas de données
Jianhua Ling
Independent Directorno dataCN¥264.00kpas de données
Yongjian Chen
Chairman of the Supervisory Boardno datapas de donnéespas de données
Li Qin Zhou
Supervisorno datapas de donnéespas de données
Xiaofeng Zou
Employee Representative Supervisorno datapas de donnéespas de données
Xia Fan
Independent Directorless than a yearpas de donnéespas de données

0.8yrs

Durée moyenne de l'emploi

54.5yo

Âge moyen

Conseil d'administration expérimenté: Le conseil d'administration de la 603882 n'est pas considéré comme expérimenté ( 0.8 années d'ancienneté moyenne), ce qui suggère un nouveau conseil d'administration.